EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Chimeric Antigen Receptor Delivery Approaches in the Era of Regulatory-Approved T-cell Products for Cancer Immunotherapy

Setareh Dashti Shokoohi, Mehdi Sheikhi, Pouya Safarzadeh Kozani, Pooria Safarzadeh Kozani, Mehdi Rabiee Valashedi, Chia Bamshad, Amirsadegh Nikoo, Abdolkarim Sheikhi

Trends in Medical Sciences · 2023

DOI: 10.5812/tms-131916 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Trends in Medical Sciences, 2023. Verfasst von Setareh Dashti Shokoohi und 7 weiteren Autor:innen. Die Arbeit nennt 12 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Shokoohi, S. D., Sheikhi, M., Kozani, P. S., Kozani, P. S., Valashedi, M. R., Bamshad, C., Nikoo, A., & Sheikhi, A. (2023). Chimeric Antigen Receptor Delivery Approaches in the Era of Regulatory-Approved T-cell Products for Cancer Immunotherapy. Trends in Medical Sciences. https://doi.org/10.5812/tms-131916

Vancouver

Shokoohi SD, Sheikhi M, Kozani PS, Kozani PS, Valashedi MR, Bamshad C, et al. Chimeric Antigen Receptor Delivery Approaches in the Era of Regulatory-Approved T-cell Products for Cancer Immunotherapy. Trends in Medical Sciences. 2023. doi:10.5812/tms-131916

BibTeX
@article{Shokoohi2023,
  author = {Shokoohi, Setareh Dashti and Sheikhi, Mehdi and Kozani, Pouya Safarzadeh and Kozani, Pooria Safarzadeh and Valashedi, Mehdi Rabiee and Bamshad, Chia and Nikoo, Amirsadegh and Sheikhi, Abdolkarim},
  title = {Chimeric Antigen Receptor Delivery Approaches in the Era of Regulatory-Approved T-cell Products for Cancer Immunotherapy},
  journal = {Trends in Medical Sciences},
  year = {2023},
  doi = {10.5812/tms-131916}
}
Kostenlos starten →